细胞系开发血清市场预计将从 2019 年的 9.1558 亿美元增至 2027 年的 14.6792 亿美元。预计 2020 年至 2027 年该市场将以 6.1% 的复合年增长率增长。
再生医学有潜力替代或治愈组织和器官,并使先天性缺陷正常化。某些与年龄相关的异常、疾病和创伤会损害组织和器官。在一个世纪的最后十年中,组织工程行业令人瞩目地崛起,现已发展成为更广泛的再生医学领域,其重点是开发用于维持、修复、替代和增强生物功能的临床疗法,利用细胞工程。细胞系开发是再生医学至关重要且不变的部分。因此,再生医学的进步增加了对细胞系开发中使用的血清的需求。
细胞系在药物的测试和开发、细胞-基于治疗、与癌症组织相关的研究等应用。制药公司开发的新药在分化干细胞上进行安全有效的测试,以检查其潜力。此外,使用细胞模型的再生医学有可能帮助研究人员对退行性疾病和创伤进行早期干预治疗。因此,再生药物使用的激增推动了细胞系开发血清市场。
细胞系开发血清利润丰厚的区域市场
< br />
市场洞察
越来越多地采用再生药物
再生药物具有替代或治愈组织的潜力以及器官,并使先天性缺陷正常化。某些与年龄相关的异常、疾病和创伤会损害组织和器官。在一个世纪的最后十年中,组织工程行业令人瞩目地崛起,现已发展成为更广泛的再生医学领域,其重点是开发用于维持、修复、替代和增强生物功能的临床疗法,利用细胞工程。细胞系开发是再生医学至关重要且不变的部分。因此,再生医学的进步增加了对细胞系开发中使用的血清的需求。
细胞系有助于药物的测试和开发、细胞疗法的开发以及相关研究除其他应用外,还可以用于癌症组织。制药公司开发的新药在分化干细胞上进行安全有效的测试,以检查其潜力。此外,使用细胞模型的再生医学有可能帮助研究人员对退行性疾病和创伤进行早期干预治疗。因此,再生药物使用的激增推动了细胞系开发血清市场。
类型见解
根据类型,细胞系开发血清市场分为胎牛血清、成体牛血清、猪血清、马血清和其他动物血清。 2019年,胎牛血清细分市场占据最大市场份额。该细分市场的增长归因于血液检测、尿液检测和不同成像程序的增加。
全球细胞系开发血清市场(按类型) 2019年和2027年
最终用户洞察
基于应用,全球细胞系开发血清市场分为组织工程和再生医学、毒性测试、研究、药物发现、生物生产。 2019年,生物生产领域占据最大市场份额;而药物发现领域预计在预测期内将实现市场上最高的复合年增长率。
战略见解
产品发布和批准是公司扩大全球足迹和产品组合以满足不断增长的消费者需求的普遍采用的策略。细胞系开发血清市场参与者采用合作策略来扩大全球客户群,这也使他们能够在全球范围内维持其品牌名称。
细胞系开发血清市场 -按类型
- 胎牛血清
- 成体牛血清
- 猪血清
- 马血清
- 其他动物血清
细胞系开发血清市场 –按应用
- 生物生产
- 药物发现
- 组织工程和再生药物
- 毒性测试
- 学术研究
细胞系开发血清市场 -按地理位置
- 北美洲
- 美国
- 加拿大
- 墨西哥
< li>欧洲 - 法国
- 德国
- 意大利
- 英国
- 西班牙
- 休息欧洲
- 亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太地区其他地区
- 中东和非洲非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东其他地区和地区非洲
- 南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲其他地区
公司简介
- Lonza
- Thermo Fisher Scientific Inc.< /li>
- Sigma-Aldrich 公司(默克公司)
- (Cytiva)丹纳赫
- PAN Biotech
- 康宁公司
- 欧洲细胞培养保藏中心 (ECACC)
- Bovogen Biologicals Pty Ltd.
- 药明康德
- 美国典型培养物保藏中心 (ATCC) 集团
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The cell line is established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from other cells. The cell line development market growth is mainly attributed to the serum is broadly important as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. Besides, the serum also regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.
Increasing Adoption of Regenerative Medicines s expected to propel the growth of the Cell Line Development Serum market. Moreover, rising R&D investments and collaborations among by pharmaceutical and biotechnology companies.
The price of Cell Line Development Serum treatment is $ 168.80 for for fetal bovine serum and HyClone Cosmic Calf Serum, New Zealand origin cost at $ 256.00 USD. However, the cost profoundly differs based upon the customization
The List of Companies - Cell Line Development Serum Market
- Lonza
- Thermo Fisher Scientific Inc.,
- Sigma-Aldrich Corporation (MERCK KGaA)
- Cytiva (Danaher)
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)